Arcus Biosciences, Inc.
TREATMENT OF ONCOGENE-DRIVEN CANCERS

Abstract:

The present disclosure provides methods of treating a subject identified as having an oncogene driven cancer comprising administering to said subject an agent targeting the extracellular production of adenosine and/or an agent antagonizing the activation by adenosine of one of its receptors.